Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chronic periodontitis
(ChP) is a multifactorial disease influenced by microbial and host genetic variability; however, the role of beta-defensin-2 genomic (
DEFB4
) copy number (CN) variation (V) in ChP remains unknown. The association of the occurrence and severity of ChP and
DEFB4
CNV was analyzed. Our study included 227 unrelated Caucasians, that is, 136 ChP patients (combined ChP) and 91 control individuals. The combined ChP group was subdivided into the severe ChP and slight-to-moderate ChP subgroups. To determine
DEFB4
CNV, we isolated genomic DNA samples and analyzed them by relative quantitation using the comparative CT method. The serum beta-defensin-2 (hBD-2) level was determined via ELISA. The distribution pattern and mean
DEFB4
CN did not differ significantly in combined ChP cases vs. the controls; however, the mean
DEFB4
CN in the severe ChP group differed significantly from those for the control and slight-to-moderate ChP groups. Low
DEFB4
CN increased the risk of severe ChP by about 3-fold.
DEFB4
CN was inversely associated with average attachment loss. Mean serum hBD-2 levels were highest in the controls, followed by the slight-to-moderate ChP group and the severe ChP group. The results suggested an association between decreased
DEFB4
CN and serum hBD-2 levels and
periodontitis
severity.
...
PMID:Beta-defensin-2 genomic copy number variation and chronic periodontitis. 2401 64